XTRA:COP

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Compugroup Medical SE KGaA

Executive Summary

Compugroup Medical SE & Co. KGaA develops and sells software and information technology services for the healthcare sector worldwide. More Details


Snowflake Analysis

Adequate balance sheet average dividend payer.


Similar Companies

Share Price & News

How has Compugroup Medical SE KGaA's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: COP is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: COP's weekly volatility (5%) has been stable over the past year.


Market Performance


7 Day Return

6.5%

COP

4.3%

DE Healthcare Services

1.3%

DE Market


1 Year Return

32.2%

COP

32.2%

DE Healthcare Services

1.4%

DE Market

Return vs Industry: COP exceeded the German Healthcare Services industry which returned 29.5% over the past year.

Return vs Market: COP exceeded the German Market which returned 0.9% over the past year.


Shareholder returns

COPIndustryMarket
7 Day6.5%4.3%1.3%
30 Day12.3%10.6%13.0%
90 Day9.8%10.6%2.6%
1 Year33.0%32.2%33.0%32.2%4.6%1.4%
3 Year48.0%44.6%46.0%42.7%5.7%-3.5%
5 Year145.4%135.8%147.9%137.7%25.7%8.0%

Long-Term Price Volatility Vs. Market

How volatile is Compugroup Medical SE KGaA's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Compugroup Medical SE KGaA undervalued compared to its fair value and its price relative to the market?

52.42x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: COP (€82) is trading above our estimate of fair value (€48.58)

Significantly Below Fair Value: COP is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: COP is poor value based on its PE Ratio (52.4x) compared to the XE Healthcare Services industry average (44.1x).

PE vs Market: COP is poor value based on its PE Ratio (52.4x) compared to the German market (23.1x).


Price to Earnings Growth Ratio

PEG Ratio: COP is poor value based on its PEG Ratio (4x)


Price to Book Ratio

PB vs Industry: COP is overvalued based on its PB Ratio (7x) compared to the DE Healthcare Services industry average (3.4x).


Next Steps

Future Growth

How is Compugroup Medical SE KGaA forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

13.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: COP's forecast earnings growth (13% per year) is above the savings rate (0.2%).

Earnings vs Market: COP's earnings (13% per year) are forecast to grow slower than the German market (27.3% per year).

High Growth Earnings: COP's earnings are forecast to grow, but not significantly.

Revenue vs Market: COP's revenue (6.4% per year) is forecast to grow faster than the German market (5.8% per year).

High Growth Revenue: COP's revenue (6.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: COP's Return on Equity is forecast to be high in 3 years time (24.1%)


Next Steps

Past Performance

How has Compugroup Medical SE KGaA performed over the past 5 years?

18.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: COP has high quality earnings.

Growing Profit Margin: COP's current net profit margins (9.3%) are lower than last year (11.4%).


Past Earnings Growth Analysis

Earnings Trend: COP's earnings have grown by 18.5% per year over the past 5 years.

Accelerating Growth: COP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: COP had negative earnings growth (-10.6%) over the past year, making it difficult to compare to the Healthcare Services industry average (-14.6%).


Return on Equity

High ROE: COP's Return on Equity (12.2%) is considered low.


Next Steps

Financial Health

How is Compugroup Medical SE KGaA's financial position?


Financial Position Analysis

Short Term Liabilities: COP's short term assets (€379.5M) exceed its short term liabilities (€231.1M).

Long Term Liabilities: COP's short term assets (€379.5M) do not cover its long term liabilities (€562.8M).


Debt to Equity History and Analysis

Debt Level: COP's debt to equity ratio (66.5%) is considered high.

Reducing Debt: COP's debt to equity ratio has reduced from 198% to 66.5% over the past 5 years.

Debt Coverage: COP's debt is well covered by operating cash flow (30.5%).

Interest Coverage: COP's interest payments on its debt are well covered by EBIT (21.3x coverage).


Balance Sheet


Next Steps

Dividend

What is Compugroup Medical SE KGaA current dividend yield, its reliability and sustainability?

0.61%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: COP's dividend (0.61%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.14%).

High Dividend: COP's dividend (0.61%) is low compared to the top 25% of dividend payers in the German market (3.66%).


Stability and Growth of Payments

Stable Dividend: COP's dividends per share have been stable in the past 10 years.

Growing Dividend: COP's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (32%), COP's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: COP's dividends in 3 years are forecast to be well covered by earnings (18% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.8yrs

Average management tenure


CEO

Frank Gotthardt (70 yo)

12.33yrs

Tenure

€4,021,138

Compensation

Mr. Frank Gotthardt has been the Chairman of Management Board and Chief Executive Officer of CompuGroup Medical SE & Co. KGaA (formerly known as CompuGroup Medical Societas Europaea) (formerly, CompuGroup ...


CEO Compensation Analysis

Compensation vs Market: Frank's total compensation ($USD4.81M) is about average for companies of similar size in the German market ($USD4.06M).

Compensation vs Earnings: Frank's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Frank Gotthardt
Chairman of Management Board & CEO12.33yrs€4.02m33.33%
€ 1.5b
Michael Rauch
CFO & Member of Management Board1.25yrs€666.39k0.0041%
€ 180.2k
Hannes Reichl
MD of Hospital Information Systems & Member of the Management Board2yrs€736.88k0.0028%
€ 122.9k
Frank Brecher
CTO & Member of Management Board5.58yrs€589.15k0.0024%
€ 105.3k
Ralph Körfgen
MD of Ambulatory & Pharmacy Information Systems and Member of Management Board2yrs€761.19kno data
Eckart Pech
MD of Consumer & Health Management Information Systems and Member of the Management Board1yr€473.51kno data
Claudia Thomé
Head of Investor Relationsno datano datano data
Benedikt Brückle
Senior Vice President of Northern America & Canada3.83yrsno datano data
Oliver Bruzek
Chief Communication Officer of Political & Public Affairsno datano datano data
Gerhard Schütz
Senior Vice President of Asian & African Region5.83yrsno datano data
Franck Frayer
Senior Vice President of Physician Information Systems Europe3.83yrsno datano data
Lars Henze
Senior Vice President of Dental Information Systems Europe3.83yrsno datano data

3.8yrs

Average Tenure

51yo

Average Age

Experienced Management: COP's management team is considered experienced (3.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Klaus Esser
Independent Chairman of Supervisory Board6.5yrs€90.00k0.26%
€ 11.5m
Philipp von Ilberg
Member of Supervisory Board0.50yrno datano data
Daniel Gotthardt
Deputy Chairman of Supervisory Boardno data€60.00k6.65%
€ 292.9m
Dierk Heimann
Member of Medical Advisory Boardno datano datano data
Ulrike Handel
Independent Member of Supervisory Board3.5yrs€60.00kno data
Maik Pagenkopf
Employee Representative Supervisory Board Member4.75yrs€60.00kno data
Klaus Schrod
Employee Representative Supervisory Board Member4.75yrs€60.00kno data

4.8yrs

Average Tenure

Experienced Board: COP's board of directors are considered experienced (4.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.9%.


Top Shareholders

Company Information

Compugroup Medical SE & Co. KGaA's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Compugroup Medical SE & Co. KGaA
  • Ticker: COP
  • Exchange: XTRA
  • Founded:
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: €4.406b
  • Shares outstanding: 53.73m
  • Website: https://www.cgm.com

Number of Employees


Location

  • Compugroup Medical SE & Co. KGaA
  • Maria Trost 21
  • Koblenz
  • Rhineland-Palatinate
  • 56070
  • Germany

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
COPDB (Deutsche Boerse AG)YesCommon SharesDEEURJul 1996
0MSDLSE (London Stock Exchange)YesCommon SharesGBEURJul 1996
CMPV.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDJul 1996
COPXTRA (XETRA Trading Platform)YesCommon SharesDEEURJul 1996
COPDBATS-CHIXE (BATS 'Chi-X Europe')YesCommon SharesGBEURJul 1996
COP2WBAG (Wiener Boerse AG)YesCommon SharesATEURJul 1996
COMPGSWX (SIX Swiss Exchange)YesCommon SharesCHCHFJul 1996
COPETLX (Eurotlx)YesCommon SharesITEURJul 1996
COP1 NBMV (Bolsa Mexicana de Valores)YesCommon SharesMXMXNJul 1996
CMPU.YOTCPK (Pink Sheets LLC)ADRUSUSDMar 2012
COPADB (Deutsche Boerse AG)ADRDEEURMar 2012

Biography

Compugroup Medical SE & Co. KGaA develops and sells software and information technology services for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pha...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/11/27 20:15
End of Day Share Price2020/11/27 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.